Literature DB >> 31794247

Explaining Gene Expression Using Twenty-One MicroRNAs.

Amir Asiaee1, Zachary B Abrams2, Samantha Nakayiza2, Deepa Sampath3, Kevin R Coombes2.   

Abstract

The transcriptome of a tumor contains detailed information about the disease. Although advances in sequencing technologies have generated larger data sets, there are still many questions about exactly how the transcriptome is regulated. One class of regulatory elements consists of microRNAs (or miRs), many of which are known to be associated with cancer. To better understand the relationships between miRs and cancers, we analyzed ∼9000 samples from 32 cancer types studied in The Cancer Genome Atlas. Our feature reduction algorithm found evidence for 21 biologically interpretable clusters of miRs, many of which were statistically associated with a specific type of cancer. Moreover, the clusters contain sufficient information to distinguish between most types of cancer. We then used linear models to measure, genome-wide, how much variation in gene expression could be explained by the 21 average expression values ("scores") of the clusters. Based on the ∼20,000 per-gene R2 values, we found that (1) mean differences between tissues of origin explain about 36% of variation; (2) the 21 miR cluster scores explain about 30% of the variation; and (3) combining tissue type with the miR scores explained about 56% of the total genome-wide variation in gene expression. Our analysis of poorly explained genes shows that they are enriched for olfactory receptor processes, sensory perception, and nervous system processing, which are necessary to receive and interpret signals from outside the organism. Therefore, it is reasonable for those genes to be always active and not get downregulated by miRs. In contrast, highly explained genes are characterized by genes translating to proteins necessary for transport, plasma membrane, or metabolic processes that are heavily regulated processes inside the cell. Other genetic regulatory elements such as transcription factors and methylation might help explain some of the remaining variation in gene expression.

Entities:  

Keywords:  feature extraction; gene expression prediction; gene regulation; mRNA; microRNA

Year:  2019        PMID: 31794247      PMCID: PMC7398443          DOI: 10.1089/cmb.2019.0321

Source DB:  PubMed          Journal:  J Comput Biol        ISSN: 1066-5277            Impact factor:   1.479


  23 in total

1.  Mapping and quantifying mammalian transcriptomes by RNA-Seq.

Authors:  Ali Mortazavi; Brian A Williams; Kenneth McCue; Lorian Schaeffer; Barbara Wold
Journal:  Nat Methods       Date:  2008-05-30       Impact factor: 28.547

Review 2.  Targeting microRNAs in cancer: rationale, strategies and challenges.

Authors:  Ramiro Garzon; Guido Marcucci; Carlo M Croce
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

Review 3.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

Authors:  Rajesha Rupaimoole; Frank J Slack
Journal:  Nat Rev Drug Discov       Date:  2017-02-17       Impact factor: 84.694

4.  miEAA: microRNA enrichment analysis and annotation.

Authors:  Christina Backes; Qurratulain T Khaleeq; Eckart Meese; Andreas Keller
Journal:  Nucleic Acids Res       Date:  2016-04-29       Impact factor: 16.971

5.  Thresher: determining the number of clusters while removing outliers.

Authors:  Min Wang; Zachary B Abrams; Steven M Kornblau; Kevin R Coombes
Journal:  BMC Bioinformatics       Date:  2018-01-08       Impact factor: 3.169

Review 6.  The role of MicroRNAs in human cancer.

Authors:  Yong Peng; Carlo M Croce
Journal:  Signal Transduct Target Ther       Date:  2016-01-28

Review 7.  Clinical applications of microRNAs.

Authors:  Per Hydbring; Gayane Badalian-Very
Journal:  F1000Res       Date:  2013-06-06

Review 8.  Tools for Sequence-Based miRNA Target Prediction: What to Choose?

Authors:  Ángela L Riffo-Campos; Ismael Riquelme; Priscilla Brebi-Mieville
Journal:  Int J Mol Sci       Date:  2016-12-09       Impact factor: 5.923

9.  Observation weights unlock bulk RNA-seq tools for zero inflation and single-cell applications.

Authors:  Koen Van den Berge; Fanny Perraudeau; Charlotte Soneson; Michael I Love; Davide Risso; Jean-Philippe Vert; Mark D Robinson; Sandrine Dudoit; Lieven Clement
Journal:  Genome Biol       Date:  2018-02-26       Impact factor: 13.583

10.  Discovering functional impacts of miRNAs in cancers using a causal deep learning model.

Authors:  Lujia Chen; Xinghua Lu
Journal:  BMC Med Genomics       Date:  2018-12-31       Impact factor: 3.063

View more
  2 in total

1.  MiR-1270 Suppresses the Malignant Progression of Breast Cancer via Targeting MMD2.

Authors:  Shaojun Hu; Yang Song; Yu Zhou; Yu Jiao; Song Wang
Journal:  J Healthc Eng       Date:  2022-03-19       Impact factor: 2.682

2.  miR-1207-5p Can Contribute to Dysregulation of Inflammatory Response in COVID-19 via Targeting SARS-CoV-2 RNA.

Authors:  Giorgio Bertolazzi; Chiara Cipollina; Panayiotis V Benos; Michele Tumminello; Claudia Coronnello
Journal:  Front Cell Infect Microbiol       Date:  2020-10-29       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.